Omnicell Q4 revenue $307M (+19% YoY); 2025 guides ARR $610-630M, product bookings $500-550M

OMNICELL, INC.

2024-FY EPS reported $0.27 revenue$1,112,238,000

Q4 total revenues $307M, up 19% YoY; GAAP net income $16M ($0.34 diluted) vs loss of $14M in Q4 2023.
Full year 2024 revenues $1.112B, down 3% YoY; GAAP net income $13M ($0.27) vs loss of $20M in 2023.
Bookings for 2024 were $923M, up 8% YoY; backlog $1.20B. Introduced new metrics: product bookings $558M, ARR $580M.
2025 guidance: total revenues $1.105-1.155B; non-GAAP EBITDA $140-155M; non-GAAP EPS $1.65-1.85.
Issued $172.5M of 1.00% convertible notes due 2029; repurchased $400M of 0.25% notes due 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.